Literature DB >> 27357501

NOD2/CARD15 gene mutations in patients with gouty arthritis.

Ahmet Karaarslan1, Senol Kobak, Afig Berdeli.   

Abstract

Nucleotide binding and oligomerization domains/caspase recruitment domain-containing protein 15 (NOD2/CARD15) is a cytoplasmic molecule controlling apoptosis and inflammatory processes by recognizing some microbial components. We aimed to identify the frequencies of NOD2/CARD15 gene mutations in patients with gouty arthritis and to determine their possible correlation with the disease phenotype. The study included 93 patients with gouty arthritis and 51 healthy controls matched for age, gender, and ethnicity. The NOD2/CARD15 R702W and G908R gene mutations were explored by the polymerase chain reaction restriction fragment length polymorphism method while the 3020insC mutation was analyzed by DNA sequencing. The mean patient age was 54.2 ± 14.2 years and mean duration of the disease was 3.1 ± 2.9 years. The first metatarsophalangeal and finger joint involvements were detected in 72 (77.4%) and 18 (19.5%) patients, respectively. Ankle arthritis and knee arthritis were detected in 43 (46.2%) and 20 (21.5%) patients, respectively. In total, 4 (9%) heterozygous mutations were detected in the G908R and R702W genes, while no mutation was detected in the 3020insC gene. Compared to the control group, there were no significant differences in all three DNA regions (G908R, R702W, and 3020insC; p = 0.452, p = 0.583, and p = 0.350, respectively). No correlation between the NOD2/CARD15 variants and clinical or laboratory findings (p > 0.05) was found. The frequencies of the NOD2/CARD15 gene mutations in the patients were similar to healthy control group. No association between clinical or laboratory findings and the NOD2/CARD15 gene mutations was observed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27357501      PMCID: PMC5136763          DOI: 10.17305/bjbms.2016.1339

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  18 in total

1.  CARD15 gene mutations are not associated with ankylosing spondylitis.

Authors:  M van der Paardt; J B A Crusius; M H M T de Koning; L S Murillo; R J van de Stadt; B A C Dijkmans; A S Peña; I E van der Horst-Bruinsma
Journal:  Genes Immun       Date:  2003-01       Impact factor: 2.676

2.  Analysis of CARD15 polymorphisms in Korean patients with ankylosing spondylitis reveals absence of common variants seen in western populations.

Authors:  Tae-Hwan Kim; Proton Rahman; Jae-Bum Jun; Hye-Soon Lee; Yong-Wook Park; Ho Joon Im; Tara Snelgrove; Lynette Peddle; David Hallett; Robert D Inman
Journal:  J Rheumatol       Date:  2004-10       Impact factor: 4.666

Review 3.  The role of interleukin-1 and the inflammasome in gout: implications for therapy.

Authors:  Richard M Pope; Jürg Tschopp
Journal:  Arthritis Rheum       Date:  2007-10

4.  Mapping of a susceptibility locus for Crohn's disease on chromosome 16.

Authors:  J P Hugot; P Laurent-Puig; C Gower-Rousseau; J M Olson; J C Lee; L Beaugerie; I Naom; J L Dupas; A Van Gossum; M Orholm; C Bonaiti-Pellie; J Weissenbach; C G Mathew; J E Lennard-Jones; A Cortot; J F Colombel; G Thomas
Journal:  Nature       Date:  1996-02-29       Impact factor: 49.962

5.  CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease.

Authors:  D Laukens; H Peeters; D Marichal; B Vander Cruyssen; H Mielants; D Elewaut; P Demetter; C Cuvelier; M Van Den Berghe; P Rottiers; E M Veys; E Remaut; L Steidler; F De Keyser; M De Vos
Journal:  Ann Rheum Dis       Date:  2004-11-11       Impact factor: 19.103

6.  NOD2/CARD15 mutations in Turkish patients with ankylosing spondylitis.

Authors:  S Kobak; M Orman; A Berdeli
Journal:  Scand J Rheumatol       Date:  2013-02-15       Impact factor: 3.641

7.  Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease.

Authors:  H Peeters; B Vander Cruyssen; D Laukens; P Coucke; D Marichal; M Van Den Berghe; C Cuvelier; E Remaut; H Mielants; F De Keyser; M D Vos
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

8.  Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation.

Authors:  Olga Gutierrez; Carlos Pipaon; Naohiro Inohara; Ana Fontalba; Yasunori Ogura; Felipe Prosper; Gabriel Nunez; Jose L Fernandez-Luna
Journal:  J Biol Chem       Date:  2002-08-22       Impact factor: 5.157

9.  NOD2 allele variants in patients with rheumatoid arthritis.

Authors:  Andrzej Pawlik; Mateusz Kurzawski; Barbara Gawronska-Szklarz; Marek Drozdzik; Magdalena Herczynska
Journal:  Clin Rheumatol       Date:  2006-09-15       Impact factor: 3.650

10.  A new category of autoinflammatory disease associated with NOD2 gene mutations.

Authors:  Qingping Yao; Lan Zhou; Philip Cusumano; Nilanjana Bose; Melissa Piliang; Bijal Jayakar; Le-Chu Su; Bo Shen
Journal:  Arthritis Res Ther       Date:  2011-09-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.